These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2328034)

  • 1. Serum activity that confers acid lability to alpha-interferon in systemic lupus erythematosus: its association with disease activity and its independence from circulating alpha-interferon.
    Yee AM; Yip YK; Fischer HD; Buyon JP
    Arthritis Rheum; 1990 Apr; 33(4):563-8. PubMed ID: 2328034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus.
    Klippel JH; Carette S; Preble OT; Friedman RM; Grimley PM
    Ann Rheum Dis; 1985 Feb; 44(2):104-8. PubMed ID: 2983625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile.
    Yee AM; Buyon JP; Yip YK
    J Exp Med; 1989 Mar; 169(3):987-93. PubMed ID: 2926326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus.
    Kellner ES; Lee PY; Li Y; Switanek J; Zhuang H; Segal MS; Sobel ES; Satoh M; Reeves WH
    J Neuroimmunol; 2010 Jun; 223(1-2):13-9. PubMed ID: 20416954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus.
    von Wussow P; Jakschies D; Hartung K; Deicher H
    Rheumatol Int; 1988; 8(5):225-30. PubMed ID: 3266358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
    Lood C; Tydén H; Gullstrand B; Klint C; Wenglén C; Nielsen CT; Heegaard NH; Jönsen A; Kahn R; Bengtsson AA
    PLoS One; 2015; 10(4):e0125109. PubMed ID: 25897671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-labile alpha interferon.
    N Engl J Med; 1984 Apr; 310(14):922-4. PubMed ID: 6700681
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus.
    Abdel Galil SM; El-Shafey AM; Abdul-Maksoud RS; El-Boshy M
    Lupus; 2018 Feb; 27(2):199-209. PubMed ID: 28659049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study of serum interferon in systemic lupus erythematosus and its significance.
    Shi SY; Feng SF; Wen YM; He LF; Huang YX
    Chin Med J (Engl); 1986 Mar; 99(3):229-34. PubMed ID: 3095051
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible involvement of interferon alfa in the pathogenesis of fever in systemic lupus erythematosus.
    Kanayama Y; Kim T; Inariba H; Negoro N; Okamura M; Takeda T; Inoue T
    Ann Rheum Dis; 1989 Oct; 48(10):861-3. PubMed ID: 2818022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
    Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
    Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of lupus inclusions by sera from patients with systemic lupus erythematosus.
    Rich SA; Owens TR; Anzola MC; Bartholomew LE
    Arthritis Rheum; 1986 Apr; 29(4):501-7. PubMed ID: 3486663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [alpha-Interferon indices in systemic lupus erythematosus and the effect of interferon therapy].
    Barinskiĭ IF; Alekberova ZS; Savinov VA; Pitenov VA; Kuznetsov VP
    Vopr Virusol; 1983; 28(6):733-6. PubMed ID: 6670258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.
    Karageorgas TP; Tseronis DD; Mavragani CP
    J Biomed Biotechnol; 2011; 2011():273907. PubMed ID: 22162633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon response to dipyridamole in lupus erythematosus patients.
    Konstantinov K; Galabov A; Mastikova M
    Br J Dermatol; 1989 Jul; 121(1):59-63. PubMed ID: 2757956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon inhibitor in the blood of patients with systemic lupus erythematosus.
    Chadha KC; Ambrus JL; Stadler I; Ambrus JL
    J Biol Regul Homeost Agents; 1991; 5(1):1-9. PubMed ID: 1715634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.